From Research to Resilience: Harlow’s Role in Building the UK’s Health Security Future

Harlow Secures Multi-Billion Pound Biosecurity Investment – A Catalyst for Innovation and Growth at Arise

Harlow is set to become a global leader in life sciences and innovation, following the UK Government’s announcement of a multi-billion-pound investment in a new National Biosecurity Centre (NBC). This world-class facility, to be based in Harlow, Essex, will be the largest of its kind in Europe and is expected to create around 1,600 new jobs [1].

The NBC will consolidate vital research and testing currently spread across UK Health Security Agency (UKHSA) sites, accelerating the development of life-saving vaccines and treatments. This landmark investment not only strengthens the UK’s pandemic preparedness but also positions Harlow as a national hub for scientific excellence and economic growth.

For businesses based at Arise Innovation Hubs, this is a game-changing opportunity. Located just minutes from the future NBC site, Arise offers entrepreneurs and innovators direct access to a thriving ecosystem of research, talent, and collaboration. As part of Anglia Ruskin University, Arise is perfectly placed to help life science and health tech companies scale and succeed.

“This investment cements Harlow’s status as a centre for cutting-edge science and innovation,” said Beverley Vaughan, Arise Innovation Hubs Director. “We’re excited to support the next generation of businesses that will benefit from this transformative development.”

As the UK doubles down on its commitment to health resilience and scientific leadership, there’s never been a better time to grow your business in Harlow.